Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Pathological mechanisms and treatment progression of Alzheimer's disease

Zhang J, Kong G, Yang J, Pang L, Li X.

Eur J Med Res. 2025 Jul 14;30(1):625. doi: 10.1186/s40001-025-02886-9.

The Role and Pathogenesis of Tau Protein in Alzheimer's Disease

Hong X, Huang L, Lei F, Li T, Luo Y, Zeng M, Wang Z.

Biomolecules. 2025 Jun 5;15(6):824. doi: 10.3390/biom15060824.

An overview of the genes and biomarkers in Alzheimer's disease

Krishnamurthy HK, Jayaraman V, Krishna K, Wang T, Bei K, Changalath C, Rajasekaran JJ.

Ageing Res Rev. 2025 Feb;104:102599. doi: 10.1016/j.arr.2024.102599. Epub 2024 Nov 28.

Sleep disorders increase the risk of dementia, Alzheimer's disease, and cognitive decline: a meta-analysis

Ungvari Z, Fekete M, Lehoczki A, Munkácsy G, Fekete JT, Zábó V, Purebl G, Varga P, Ungvari A, Győrffy B.

Geroscience. 2025 Jun;47(3):4899-4920. doi: 10.1007/s11357-025-01637-2. Epub 2025 Apr 11.

Seronegative but Cerebrospinal Fluid-positive NMDA Receptor Encephalitis in an Alzheimer's Dementia Patient with Good Treatment Outcome: A Case Report

Lee YC, Tai YC.

Acta Neurol Taiwan. 2025 Jul 1;34(3):161-164. doi: 10.4103/ANT.ANT_113_0041. Epub 2025 Sep 29.

Pathogenesis of comorbid epilepsy in Alzheimer's disease and use of perampanel, an AMPA receptor inhibitor

Kuzuya A, Ohara T, Akamatsu N.

Expert Rev Neurother. 2025 Dec;25(12):1399-1409. doi: 10.1080/14737175.2025.2581758. Epub 2025 Oct 30.

The relationship between amyloid-β peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer's disease

Zoltowska KM, Bandera J, Hamed MB, Enzlein T, Hopf C, Ryan NS, Chávez-Gutiérrez L.

Alzheimers Res Ther. 2025 Nov 26;17(1):252. doi: 10.1186/s13195-025-01896-3.

Functional propriospinal myoclonus in Alzheimer's disease: coincidence or a new challenge?

Bergamin E, Turco F, Unti E, Del Chicca M, Ceravolo R, Tognoni G, Del Prete E.

Neurol Sci. 2025 Dec 23;47(1):34. doi: 10.1007/s10072-025-08739-x.

Plasma cytokines profile in patients with Alzheimer's and Parkinson's Disease: a comparative study in terms of inflammation

Shateri S, Khatami SH, Haghbin Toutounchi A, Rajaei S, Mahdavi M, Mahmoodi Baram S, Shahidi GA, Habibi AH, Aghamollaii V, Ghlichnia B, Safakish L, Doagoo A, Salmani F, Tafakhori A, Keramatinia A, Shahmohammadi MR, Karima S.

Int J Neurosci. 2025 Feb;135(2):158-167. doi: 10.1080/00207454.2023.2292951. Epub 2023 Dec 15.

Heavy metals exposure and Alzheimer's disease: Underlying mechanisms and advancing therapeutic approaches

Althobaiti NA.

Behav Brain Res. 2025 Jan 5;476:115212. doi: 10.1016/j.bbr.2024.115212. Epub 2024 Aug 24.

Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease

Zheng F, Dong T, Chen Y, Wang L, Peng G.

Exp Neurol. 2025 Jan;383:115021. doi: 10.1016/j.expneurol.2024.115021. Epub 2024 Oct 24.

Targeting tau in Alzheimer's and beyond: Insights into pathology and therapeutic strategies

Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A.

Ageing Res Rev. 2025 Feb;104:102639. doi: 10.1016/j.arr.2024.102639. Epub 2024 Dec 16.

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis

Canal-Garcia A, Branca RM, Francis PT, Ballard C, Winblad B, Lehtiö J, Nilsson P, Aarsland D, Pereira JB, Bereczki E.

Alzheimers Dement. 2025 Jan;21(1):e14375. doi: 10.1002/alz.14375. Epub 2024 Dec 23.

Two- and Three-Dimensional In Vitro Models of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Applications

Solana-Manrique C, Sánchez-Pérez AM, Paricio N, Muñoz-Descalzo S.

Int J Mol Sci. 2025 Jan 13;26(2):620. doi: 10.3390/ijms26020620.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias